Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in Mild to Moderate Rheumatoid Arthritis
NCT06594822Phase 3Completed
- Sponsor
- King Edward Medical University
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by King Edward Medical University. Primary endpoint: Disease Activity Score-28 at 3 months. Started Aug 2023; status: completed.
Beyond the preview
Go deeper on NCT06594822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594822.